141 related articles for article (PubMed ID: 22433929)
1. How to optimally manage growth hormone therapy: survey of Chilean pediatric endocrinologists.
García RJ; Martinez-Aguayo A; Mericq V
Horm Res Paediatr; 2012; 77(2):94-9. PubMed ID: 22433929
[TBL] [Abstract][Full Text] [Related]
2. Current practice in diagnosis and treatment of growth hormone deficiency in childhood: a survey from Turkey.
Poyrazoğlu Ş; Akçay T; Arslanoğlu İ; Atabek ME; Atay Z; Berberoğlu M; Bereket A; Bideci A; Bircan İ; Böber E; Can Ş; Cesur Y; Darcan Ş; Demir K; Dündar B; Ersoy B; Esen İ; Güven A; Kara C; Keskin M; Kurtoğlu S; Memioğlu N; Özbek MN; Özgen T; Sarı E; Şıklar Z; Şimşek E; Turan S; Yeşilkaya E; Yüksel B; Darendeliler F
J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):37-44. PubMed ID: 25800474
[TBL] [Abstract][Full Text] [Related]
3. Short stature and growth hormone therapy. A national study of physician recommendation patterns.
Cuttler L; Silvers JB; Singh J; Marrero U; Finkelstein B; Tannin G; Neuhauser D
JAMA; 1996 Aug; 276(7):531-7. PubMed ID: 8709401
[TBL] [Abstract][Full Text] [Related]
4. "Real-world" pediatric endocrine practice; how much is it influenced by physician's gender and region of practice. Results of an international survey.
Smuel K; Yeshayahu Y
J Eval Clin Pract; 2017 Aug; 23(4):866-869. PubMed ID: 28585354
[TBL] [Abstract][Full Text] [Related]
5. Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report.
Akchurin OM; Kogon AJ; Kumar J; Sethna CB; Hammad HT; Christos PJ; Mahan JD; Greenbaum LA; Woroniecki R
BMC Nephrol; 2017 May; 18(1):181. PubMed ID: 28558814
[TBL] [Abstract][Full Text] [Related]
6. Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists.
Hardin DS; Woo J; Butsch R; Huett B
Clin Endocrinol (Oxf); 2007 Jan; 66(1):85-94. PubMed ID: 17201806
[TBL] [Abstract][Full Text] [Related]
7. [Attach great importance to the standardized clinical usage and safety monitoring of recombinant human growth hormone in children].
Liang Y; Luo XP
Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):401-5. PubMed ID: 24120053
[No Abstract] [Full Text] [Related]
8. Consequences of brand switches during the course of pediatric growth hormone treatment.
Grimberg A; Feudtner C; Gordon CM
Endocr Pract; 2012; 18(3):307-16. PubMed ID: 21940275
[TBL] [Abstract][Full Text] [Related]
9. Insurance coverage, physician recommendations, and access to emerging treatments: growth hormone therapy for childhood short stature.
Finkelstein BS; Silvers JB; Marrero U; Neuhauser D; Cuttler L
JAMA; 1998 Mar; 279(9):663-8. PubMed ID: 9496983
[TBL] [Abstract][Full Text] [Related]
10. Transition care of patients with growth hormone deficiency from pediatric endocrinologists to adult endocrinologists.
Chamberlain Shea H; Levy RA
Endocr Pract; 2012; 18(2):256-68. PubMed ID: 22068249
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of concordance in growth hormone therapy.
Kapoor RR; Burke SA; Sparrow SE; Hughes IA; Dunger DB; Ong KK; Acerini CL
Arch Dis Child; 2008 Feb; 93(2):147-8. PubMed ID: 17768149
[TBL] [Abstract][Full Text] [Related]
12. Physician decisions to discontinue long-term medications using a two-stage framework: the case of growth hormone therapy.
Cuttler L; Silvers JB; Singh J; Tsai AC; Radcliffe D
Med Care; 2005 Dec; 43(12):1185-93. PubMed ID: 16299429
[TBL] [Abstract][Full Text] [Related]
13. When do short children realize they are short? Prepubertal short children's perception of height during 24 months of catch-up growth hormone treatment.
Chaplin JE; Kriström B; Jonsson B; Halldin Stenlid M; Aronson AS; Dahlgren J; Albertsson-Wikland K
Horm Res Paediatr; 2012; 77(4):241-9. PubMed ID: 22516981
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
Simon D; Alberti C; Alison M; Le Henaff L; Chevenne D; Boizeau P; Canal A; Ollivier G; Decostre V; Jacqz-Aigrain E; Carel JC; Czernichow P; Hogrel JY
J Clin Endocrinol Metab; 2013 Jul; 98(7):2746-54. PubMed ID: 23626006
[TBL] [Abstract][Full Text] [Related]
15. Evolution of IGF-1 in children born small for gestational age and with growth retardation, treated by growth hormone adapted to IGF-1 levels after 1 year.
Cabrol S; Perin L; Colle M; Coutant R; Jésuran-Perelroizen M; Le Bouc Y; Czernichow P
Horm Res Paediatr; 2011; 76(6):419-27. PubMed ID: 22156543
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone treatment for short stature in children born small for gestational age.
Jung H; Rosilio M; Blum WF; Drop SL
Adv Ther; 2008 Oct; 25(10):951-78. PubMed ID: 18836868
[TBL] [Abstract][Full Text] [Related]
17. Changes in BMI and management of patients with childhood onset growth hormone deficiency in the transition phase.
Bazarra-Castro MÁ; Sievers C; Schwarz HP; Pozza SB; Stalla GK
Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):507-10. PubMed ID: 23070828
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
Moore WV; Dana K; Frane J; Lippe B
Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
[TBL] [Abstract][Full Text] [Related]
19. Optimizing gh therapy in adults and children.
Drake WM; Howell SJ; Monson JP; Shalet SM
Endocr Rev; 2001 Aug; 22(4):425-50. PubMed ID: 11493578
[TBL] [Abstract][Full Text] [Related]
20. Summary of Expert Opinion on the Management of Children With Chronic Kidney Disease and Growth Failure With Human Growth Hormone.
Cappa M; Maghnie M; Carbone V; Chioma L; Errichiello C; Giavoli C; Giordano M; Guazzarotti L; Klain A; Montini G; Murer L; Parpagnoli M; Pecoraro C; Pesce S; Verrina E
Front Endocrinol (Lausanne); 2020; 11():587. PubMed ID: 33013690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
